// App-Quantinova.ai

: Efficacy of Apremilast in Patients With Mild to Moderate Psoriasis Assessed by the Physician Global Assessment and Body Surface Area Composite Tool: Post Hoc Analysis From ADVANCE

Researchers

Presenter

  • Linda Stein Gold

Principal Investigators

  • Kim Papp

  • David Pariser

  • Howard Sofen

  • Mindy Chen

  • Sue Cheng

  • Hernan Picard

  • Yuri Klyachkin

  • Lawrence Green

Medical Centers

  • Henry Ford Health System, West Bloomfield, MI, USA

  • Probity Clinical Research, Waterloo, ON, Canada

  • Probity Clinical Research, Waterloo, ON, Canada

  • Eastern Virginia Medical School and Virginia Clinical Research, Inc, Norfolk, VA

  • UCLA School of Medicine, Los Angeles, CA

  • Dermatology Research Associates, Los Angeles, CA

  • Amgen Inc, Thousand Oaks, CA

  • Department of Dermatology, George Washington University School of Medicine, Washington, DC, USA

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • Apremilast

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • N/A

Study Id's

  • NCT03721172

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved